| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
86 |
| issn |
1473-6810
1356-5524 |
| issueIdentifier |
3 |
| pageRange |
83-86 |
| publicationName |
Evidence Based Medicine |
| startingPage |
83 |
| bibliographicCitation |
Mayer M. Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the 'breakthrough'. Evid Based Med. 2016 Jun;21(3):83–6. doi: 10.1136/ebmed-2015-110325. PMID: 26718821. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3210-2274
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08d9a31ad0d55401a09ca131d98fb85a |
| date |
2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1136/ebmed-2015-110325
https://pubmed.ncbi.nlm.nih.gov/26718821 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32137
https://portal.issn.org/resource/ISSN/1473-6810
https://portal.issn.org/resource/ISSN/1356-5524 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the ‘breakthrough’ |
| discusses |
http://id.nlm.nih.gov/mesh/M0483258
http://id.nlm.nih.gov/mesh/M0000958
http://id.nlm.nih.gov/mesh/M0006823
http://id.nlm.nih.gov/mesh/M0000964
http://id.nlm.nih.gov/mesh/M0023650
http://id.nlm.nih.gov/mesh/M000607520 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16220172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71494926
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16678941 |